Pharmaceutical Technology
DECEMBER 1, 2024
The HIV vaccine space has seen dwindling research activity as drug manufacturers turn to PrEP therapies for preventive treatment.
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 1, 2024
(uzhursky/Getty Images) For roughly one in every hundred people, food containing even the smallest amounts of gluten can deliver a gutful of hurt.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Commerce
DECEMBER 1, 2024
Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
JAMA Internal Medicine
DECEMBER 1, 2024
This Viewpoint discusses the critical importance of prioritizing social determinants of health in reducing health disparities and advancing health equity.
Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
AuroBlog - Aurous Healthcare Clinical Trials blog
DECEMBER 1, 2024
Indian healthcare sector is increasingly turning to technology to address its fragmented payment landscape, which has long been a challenge for patients, healthcare providers, and insurers alike. The complexity arises from the coexistence of multiple payment models, including cash payments, insurance reimbursement, government schemes, and out-of-pocket expenses.
FDA Law Blog
DECEMBER 1, 2024
By Douglas B. Farquhar — A recent Warning Letter reflects an FDA citation of a company for refusing to permit FDA Investigators to take photographs during an inspection. We haven’t seen an FDA Warning Letter citing a refusal to permit photographs for years, so, just as FDA is apparently reviving these types of allegations, it is probably time for us to revive blogposts that have discussed this issue for more than a decade now.
Expert insights. Personalized for you.
264 
Let's personalize your content